Financial Summary and Combined Balance Sheet
Published on in Breakthrough Report
Published on in Breakthrough Report
A financial summary of revenue and expenditures for Children's Hospital of Philadelphia during the fiscal years of 2019, 2020 and 2021. (Fiscal year ends June 30.)
Sources of Revenue | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|
Net Patient Service Revenue | $2,713,117,000 | $2,542,766,0001 | $2,805,580,000 |
Other Operating Revenue | $318,277,000 | $198,193,000 | $147,687,000 |
Contributions2 | $88,850,000 | $87,088,000 | $81,376,000 |
Research | $303,972,000 | $249,875,000 | $259,224,000 |
Total Sources of Revenue | $3,424,216,000 | $3,077,922,000 | $3,293,867,000 |
Uses of Revenue | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|
Salaries, Wages and Employee Benefits | $1,747,728,000 | $1,634,891,000 | $1,555,862,000 |
Supplies and Expenses | $721,130,000 | $675,388,000 | $560,932,000 |
Depreciation | $196,933,000 | $192,189,000 | $178,088,000 |
Interest | $19,299,000 | $17,446,000 | $24,306,000 |
Research Expenses | $441,111,000 | $439,027,000 | $531,545,000 |
Uncompensated Care | $15,353,000 | $9,765,0003 | $166,629,000 |
Provisions for Programmatic Investments | $282,662,000 | $109,216,000 | $276,505,000 |
Total Uses of Revenue | $3,424,216,000 | $3,077,922,000 | $3,293,867,000 |
Assets | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|
Cash and Short-term Investments | $631,766,000 | $715,362,000 | $731,198,000 |
Receivables | $627,744,000 | $381,490,000 | $561,141,000 |
Other Current Assets | $232,274,000 | $232,058,000 | $154,080,000 |
Total Current Assets | $1,491,784,000 | $1,328,910,000 | $1,446,419,000 |
Investments | $4,632,292,000 | $3,240,019,000 | $3,071,647,000 |
Property, Plant & Equipment (Net) | $3,100,508,000 | $2,818,825,000 | $2,621,646,000 |
Other Assets | $315,328,000 | $112,773,000 | $112,229,000 |
Total Investment Assets | $8,048,128,000 | $6,171,617,000 | $5,805,522,000 |
Total Assets | $9,539,912,000 | $7,500,527,000 | $7,251,941,000 |
Liabilities and Net Assets | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|
Current Portion of Long-term Debt | $21,119,000 | $19,581,000 | $28,408,000 |
Accounts Payable and Accrued Expenses | $670,485,000 | $497,195,000 | $455,240,000 |
Total Current Liabilities | $691,604,000 | $516,776,000 | $483,648,000 |
Long-term Debt | $1,322,514,000 | $848,116,000 | $868,863,000 |
Other Liabilities | $495,662,000 | $300,052,000 | $377,213,000 |
Total Long-term Liabilities | $1,818,176,000 | $1,148,218,000 | $1,246,076,000 |
Unrestricted Net Assets | $6,366,424,000 | $5,287,497,000 | $5,008,554,000 |
Donor Restricted Net Assets | $663,708,000 | $548,086,000 | 513,663,000 |
Total Net Assets | $7,030,132,000 | $5,835,583,000 | $5,522,217,000 |
Total Liabilities and Net Assets | $9,539,912,000 | $7,500,577,000 | $7,251,941,000 |
(1) Net Patient Service Revenue for FY2020 includes $123,583,665 of Implicit Price Concessions (unpaid medical charges) which was previously included in Uncompensated Care.
(2) Includes unrestricted, temporarily restricted and permanently restricted contributions.
(3) $123,583,665 of Implicit Price Concessions (unpaid medical charges) for FY2020, which was included in Uncompensated Care in previous years, is now included in Net Patient Service Revenue.